FDA Approvals : Episode 1
FDA Approval for Lutathera in Neuroendocrine Tumors
Gina Columbus reports on the FDA approval to Lutathera (177Lutetium DOTA-octreotate) for the treatment of patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Related Videos
Related Content
